“Under the circumstances—including the lack of evidence regarding harm that Nike will suffer, the brevity of the stay, and New Balance’s commitment to continue collecting discovery from its foreign manufacturers—Nike has not ‘show[n] undue prejudice separate from the delay itself,'” the court said.
“Under the circumstances—including the lack of evidence regarding harm that Nike will suffer, the brevity of the stay, and New Balance’s commitment to continue collecting discovery from its foreign manufacturers—Nike has not ‘show[n] undue prejudice separate from the delay itself,'” the court said.
